日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oxytocin Attenuates Metabolic Dysfunction-associated Steatotic Liver Disease via AMPK/SREBP1c/FAS-mediated Suppression of Hepatic Lipogenesis.

催产素通过 AMPK/SREBP1c/FAS 介导的抑制肝脏脂肪生成来减轻代谢功能障碍相关的脂肪肝疾病。

Xu Yue, Lu Siqian, Wu Hongpei, Wu Haifeng, Li Ming, Zhou Meng, Chen Ting, Wang Xun, Qu Lishuai, Jin Qin, Liu Jinxia

Global trend of organoid implementation for hepatocellular carcinoma research (2005-2024): bibliometric analysis

2005-2024年肝细胞癌研究中类器官应用的全球趋势:文献计量分析

Ji, Changsheng; Zhao, Hui; Shui, Ying; Zhao, Wangpeng; Qu, Lishuai

Research progress in molecular targeted therapy for inflammatory bowel disease

炎症性肠病分子靶向治疗的研究进展

Liu, Nan; Pan, Chengye; Qu, Lishuai

Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO

通过WGCNA和LASSO方法,识别并验证了COPD合并NASH的免疫相关诊断指标和靶向治疗方法。

Hong, Jianwei; Xu, Zikai; Xu, Fangrui; Wu, Haifeng; Liu, Jinxia; Qu, Lishuai

A novel β2-AR/YB-1/β-catenin axis mediates chronic stress-associated metastasis in hepatocellular carcinoma

一种新型β2-AR/YB-1/β-catenin轴介导肝细胞癌慢性应激相关转移

Liu, Jinxia; Qu, Lishuai; Wan, Chunhua; Xiao, Mingbing; Ni, Wenkai; Jiang, Feng; Fan, Yihui; Lu, Cuihua; Ni, Runzhou

Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance

泛素特异性蛋白酶7是一个可作为药物靶点的物质,它能促进肝细胞癌的发生和化疗耐药性的产生。

Zhang, Wei; Zhang, Jingxin; Xu, Chenzhou; Zhang, Shiqing; Bian, Saiyan; Jiang, Feng; Ni, Wenkai; Qu, Lishuai; Lu, Cuihua; Ni, Runzhou; Fan, Yihui; Xiao, Mingbing; Liu, Jinxia